Proud moment for our team at SG Diagnostics as we celebrate another milestone with the publication of this newly released article, focusing on a practice-based framework for point-of-care chronic disease management.
In the article, the SG Diagnostics team shared insights from real-world community deployments and discussed the importance of shifting healthcare upstream — from treating disease to supporting earlier detection, continuous monitoring, and long-term preventive care.
The article also introduced STRIDE, a practice-driven framework designed to bridge the gap between screening and long-term health management. By focusing on continuity of care, STRIDE aims to support more actionable and accessible healthcare pathways for individuals managing chronic conditions such as diabetes and high cholesterol.
The article also further highlighted SG Diagnostics’ accessible point-of-care testing solutions, including the PreciSTM-A HbA1c Rapid Analysis System for diabetes management and the PreciSTM–C Cholesterol Monitoring System for cholesterol management. Both systems are capable of delivering lab-comparable results from a simple finger-prick blood sample within minutes.
As chronic diseases continue to rise globally, SG Diagnostics believes that empowering individuals with earlier insights and continuous care pathways will play an increasingly important role in building healthier communities.
Read the full article here: https://rdcu.be/fhn68
